EGB Call/VERBUND 23-24/ AT0000A34ZT1 /
13/05/2024 17:25:00 | Chg.-0.004 | Bid17:25:01 | Demandez à17:25:01 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.014EUR | -22.22% | - Bid taille: - |
- Ask la taille: - |
VERBUND AG INH... | 84.1109 EUR | 21/06/2024 | Call |
GlobeNewswire
22:47
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
GlobeNewswire
22:45
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Bu...
GlobeNewswire
22:45
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
22:44
Chocxo Dark Milk Chocolate Snaps Named a Winner in Good Housekeeping’s 2024 Best Snack Awards
GlobeNewswire
22:42
Jamf Announces Launch of Secondary Offering of Common Stock by Selling Stockholders and Related Comm...
GlobeNewswire
22:36
Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:33
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FAT Brands Inc...
GlobeNewswire
22:30
Farmers & Merchants Bancorp (FMCB) ranked #6 on Forbes Magazine’s List of “America’s Best Banks” for...
GlobeNewswire
22:30
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire
22:30
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conferen...
GlobeNewswire
22:30
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conf...
GlobeNewswire
22:30
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
GlobeNewswire
22:30
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
GlobeNewswire
22:30
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticip...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page